Biosimilar drug
| Biosimilar drug | |
|---|---|
| Term | Biosimilar drug |
| Short definition | biosimilar drug - (pronounced) (BY-oh-SIH-mih-ler. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
biosimilar drug - (pronounced) (BY-oh-SIH-mih-ler. . . ) biologic drug that is very similar to another biologic drug (called the reference drug) that has already been approved by the U. S. Food and Drug Administration (FDA). Biosimilars and reference medicines are made from living organisms, but can be made in different ways and from slightly different substances. To be called a biosimilar drug, a biologic drug must be proven to be just as safe, work the same way, and work in the same way as its reference drug. It must also be used in the same way, at the same dose and for the same condition as the reference medicine. Biosimilar drugs must be approved by the FDA and may cost less than the reference drug
External links
- Medical encyclopedia article on Biosimilar drug
- Wikipedia's article - Biosimilar drug
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski